Patient access to treatment remains poor. For the second year in a row, patients with chronic conditions rated health plan ...

In the final part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...

The CDMO’s new services at its Hopewell, NJ facility delivers scalable, phase-appropriate production, in-house quality ...

From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment ...

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...

The GSK Flovent example highlights the consequences for patients and pharma of the decision to eliminate the Medicaid rebate cap.

This episode of Pharma Pulse covers Bayer’s $2.3 billion cost-cutting overhaul, promising Phase III results for Eli Lilly’s ...

In an era of increasing regulatory complexity, life sciences organizations are modernizing GxP compliance through digital ...

In the seventh part of this roundtable discussion, key opinion leaders uncover how pharma companies can mitigate tariff ...

In the third part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...

In the fifth part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of US supply chain, explores how ...

A new two-phase initiative aims to streamline facility approvals, reduce reliance on foreign pharmaceutical production, and ...